108770 ⎘
Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor; Animal cells or tissues; Human cells or tissues; Vertebrate cells; Cells from the blood or the immune system Dendritic cells, e.g. Langherhans cells in the epidermis
Sub-classes:SYSTEMS AND METHODS FOR CELL CULTURING
#2CELL THERAPY
#3SYSTEMS AND METHODS FOR CELL CULTURING
#4PREPARATION METHOD FOR ADENOVIRUS P53-LOADED DENDRITIC CELL VACCINE
#5Method for Manufacturing Natural Killer T (NKT) Cell-Stimulating Dendritic Cells, Method for Manufacturing Cell Compositions containing the NKT Cell Stimulating Dendritic Cells, NKT Cell, and Cell Composition Thereof
#6NOVEL IMMUNOTHERAPY AGAINST SEVERAL TUMORS INCLUDING NEURONAL AND BRAIN TUMORS
#7MATURATION OF DENDRITIC CELLS
#8PERSONALIZED MUC1-C INDUCED PLURIPOTENT STEM CELL AND DENDRITIC CELL BASED VACCINES
#9ETHER LIPIDS FOR HYPERACTIVATION OF MAMMALIAN DENDRITIC CELLS
#10ANTI-TUMOR IMMUNE RESPONSE ENHANCER
#11CELL THERAPY COMPOSITIONS AND METHODS OF USE THEREOF
#12COMPOSITIONS AND METHODS FOR PRODUCING ANTIBODY-GENERATING IMMUNE ORGANOIDS
#13COMPOSITIONS AND METHODS OF CHIMERIC ALLOANTIGEN RECEPTOR T CELLS
#14ALDH Inhibitors to Promote Immune Cell Expansion
#15T-CELL EXPANSION METHOD AND USES
#16METHOD FOR PRODUCING MATURE DENDRITIC CELLS
#17ENGINEERED IMMUNE CELLS
#18CANCER ANTIGENS AND METHODS
#19METHODS AND COMPOSITIONS FOR TREATING GLIOMAS
#20SYSTEMS AND METHODS FOR CELL CULTURING
#21Systems For Producing Cellular Immunotherapeutics And Methods Of Use Thereof
#22ENGINEERED PROGENITOR CELLS AND METHODS OF USE
#23ALLOGENEIC EXTRACELLULAR VESICLES FOR CANCER TREATMENT
#24DAP12 CONSTRUCTS AND THEIR USE TO ENHANCE DC VACCINES AND IMMUNOTHERAPIES
#25NUCLEIC ACIDS ENCODING A CONSTITUTIVELY-ACTIVE CYCLIC GMP-AMP SYNTHASE AND IMMUNOGENIC DELIVERY VEHICLES FOR SAME
#26METHODS TO ENHANCE TUMOR IMMUNOGENICITY AND COMPOSITIONS FOR AUTOLOGOUS CANCER IMMUNOTHERAPEUTIC PRODUCTS USING MODIFIED TUMOR CELLS AND MODIFIED DENDRITIC CELLS
#27USES OF AMINO ACID-CHELATED ZINC, INCLUDING IMMUNE REGULATION AND TREATMENT OF AUTOIMMUNE DISEASE
#28METHODS AND COMPOSITIONS COMPRISING B7-H3 BINDING POLYPETIDES
#29METHODS AND COMPOSITIONS USING RECOMBINANT DENDRITIC CELLS FOR CANCER THERAPY
#30MANNOSE-TARGETED COMPOSITIONS
#31T-CELL EXPANSION METHOD AND USES
#32METHOD FOR REPROGRAMMING FIBROBLAST OR FIBROBLAST-LIKE CELL TO CONVENTIONAL TYPE-2 DENDRITIC CELL
#33REPROGRAMMING OF CELLS TO TYPE 1 CONVENTIONAL DENDRITIC CELLS OR ANTIGEN-PRESENTING CELLS
#34METHOD FOR CULTURING DENDRITIC CELLS THROUGH AMPLIFICATION AND DIFFERENTIATION OF PERIPHERAL BLOOD, AND USAGE THEREOF
#35AUTOLOGOUS CELL BASED SARS-COV-2 VACCINES
#36COMPOSITIONS AND METHODS FOR ENHANCING IMMUNE CELL FUNCTION USING MODIFIED CELLS WITH GLYCOCALYX EDITING ENZYMES
#37METHODS OF ENRICHING CELL POPULATIONS FOR CANCER-SPECIFIC T CELLS USING IN VITRO STIMULATION OF MEMORY T CELLS
#38SMALL EXTRACELLULAR VESICLES EXPRESSING A DOMINANT NEGATIVE AMPK ALPHA 1 MUTANT FOR USE IN THE TREATMENT OF OBESITY
#39BETA-GLUCAN METHODS AND COMPOSITIONS THAT AFFECT THE TUMOR MICROENVIRONMENT
#40LIGHT-INDUCED CELLULAR PRODUCTION OF IMMUNE FUNCTIONAL EXTRACELLULAR VESICLES
#41EX VIVO USE OF MODIFIED CELLS OF LEUKEMIC ORIGIN FOR ENHANCING THE EFFICACY OF ADOPTIVE CELL THERAPY
#42Method of Targeting Cells and Associated Compositions
#43Systems and Methods Incorporating Modified T-Cells
#44Dendritic Cell Generator
#45SYSTEMS AND METHODS FOR CELL CULTURING
#46HOMEOBOX TRANSCRIPTION FACTOR VENTX REGULATES DIFFERENTIATION AND MATURATION OF HUMAN DENDRITIC CELLS
#47AGENTS THAT ENGAGE ANTIGEN-PRESENTING CELLS THROUGH DENDRITIC CELL ASIALOGLYCOPROTEIN RECEPTOR (DC-ASGPR)
#48PREPARATION OF A THERAPEUTIC COMPOSITION FOR TREATING AUTOIMMUNE DISEASES
#49METHODS FOR TREATING OR PREVENTING VIRAL INFECTION
#50SHP1 MODIFIED DENDRITIC CELLS AND EXTRACELLULAR VESICLES DERIVED THEREFROM AND ASSOCIATED METHODS
#51IMMUNE CELLS WITH REDUCED ANDROGEN RECEPTOR (AR) LEVEL, AND METHODS OF THEIR USE TO ENHANCE ANTI-CANCER THERAPY
#52TUMOR AVATAR VACCINE COMPOSITIONS AND USES THEREOF
#53SYSTEMS AND METHODS FOR CELL CULTURING
#54METHODS AND COMPOSITION USING PATIENT-DERIVED AUTOLOGOUS NEOANTIGENS FOR TREATING CANCER
#55POLYMERIC MICELLE NANOPARTICLES FOR ON-DEMAND CELLULAR PACKAGING OF EXTRACELLULAR VESICLES
#56APTAMERS FOR TARGETED ACTIVATION OF T CELL-MEDIATED IMMUNITY
#57SYSTEMS AND METHODS FOR CELL CULTURING
#58Induction of Antigen Specific Immunological Tolerance Using Inducible Pluripotent Stem Cell Derived Veto Cells
#59ACTIVATION OF SURVIVIN-SPECIFIC IMMUNE RESPONSES USING DENDRITIC CELL DERIVED EXOSOMES
#60TUMOR LYSATE LOADED PARTICLES
#61METHODS OF TREATING CANCER
#62SHORT-TERM ACTIVATED DC1S AND METHODS FOR THEIR PRODUCTION AND USE
#63FLUID SHEAR STRESS FOR EX VIVO ACTIVATION OF IMMUNE EFFECTOR CELLS
#64CANCER THERAPIES COMPRISING PEPTIDE LOADED CXCR3- AND CCR5-INDUCING DENDRITIC CELLS AND CHEMOKINE MODULATORY AGENTS
#65METHOD FOR ACTIVATING DENDRITIC CELLS
#66PEPTIDES AND ENGINEERED T CELL RECEPTORS TARGETING SARS-COV-2 ANTIGENS AND METHODS OF USE
#67EPSTEIN-BARR VIRUS (EBV) ANTIGEN COMPOSITES AND DENDRITIC CELL (DC)-BASED VACCINE, AND USE THEREOF
#68METHODS OF PREPARING AN ISOLATED POPULATION OF DENDRITIC CELLS AND METHODS OF TREATING CANCER USING SAME
#69Dendritic cell generating apparatus and method
#70IN-SITU CRYO-IMMUNE ENGINEERING FOR CANCER IMMUNOTHERAPY
#71DENDRITIC CELL-DERIVED VESICLES AND ACTIVATION OF ANTIGEN-SPECIFIC T-CELLS
#72METHODS AND COMPOSITIONS FOR TARGETING OF ANTIGENS AND OTHER POLYPEPTIDES TO FIRST RESPONDER DENDRITIC CELLS
#73PATIENT SELECTION FOR TREATMENT WITH DENDRITIC CELL VACCINATION
#74COMPOUNDS FOR IMMUNOMODULATION
#75TROJAN CIRCULATING TUMOR CELLS
#76METHODS AND COMPOSITIONS COMPRISING MHC CLASS I PEPTIDES
#77SYSTEM AND METHOD OF PREPARING AND STORING ACTIVATED MATURE DENDRITIC CELLS
#78METHOD FOR CULTURING DENDRITIC CELLS
#79RETRO - INVERSO REGULATORY T CELL EPITOPES
#80CELL CULTURE SURFACES AND CONTAINERS AND METHODS FOR MAKING AND USING THEM
#81DENDRITIC PEPTIDE CONJUGATED POLYMERS FOR EFFICIENT INTRACELLULAR DELIVERY OF NUCLEIC ACIDS TO IMMUNE CELLS
#82STING DEPENDENT ADJUVANTS
#83CGMP COMPLIANT PRODUCTION AND EXPANSION OF PLASMACYTOID DENDRITIC CELLS FROM HEMATOPOIETIC STEM AND PROGENITOR CELLS
#84METHODS AND COMPOSITIONS FOR MODULATING PERIPHERAL IMMUNE FUNCTION
#85COMPOSITIONS FOR REPROGRAMMING CELLS INTO DENDRITIC CELLS TYPE 2 COMPETENT FOR ANTIGEN PRESENTATION, METHODS AND USES THEREOF
#86PATIENT SELECTION FOR TREATMENT WITH DENDRITIC CELL VACCINATION
#87COMPOUNDS FOR IMMUNOMODULATION
#88METHODS AND COMPOSITIONS FOR GENERATING AN IMMUNE RESPONSE BY INDUCING CD40 AND PATTERN RECOGNITION RECEPTOR ADAPTERS
#89IN VITRO METHODS AND COMPOSITIONS FOR ENHANCING THE ACTIVATION OF DENDRITIC CELLS AND T CELLS, AND FOR INDUCING A TH-1 IMMUNE RESPONSE
#90Human Cross-Presenting CD141+CLEC9A+ Dendritic Cells, Methods of Producing the Same from Mobilized Peripheral Blood CD34+ Hematopoietic Stem Cells and Methods of Use
#91COMPOSITIONS, SYSTEMS, AND METHODS FOR TREATING CANCER USING ALTERNATING ELECTRIC FIELDS AND DENDRITIC CELLS
#92DEVICE AND METHOD FOR OBTAINING IMMUNO-STIMULATORY ANTIGEN-PRESENTING CELLS
#93CHIMERIC TARGET FACTOR RECEPTOR
#94RECOMBINANT ADENO-ASSOCIATED VIRUS VECTORS WITH CD14 PROMOTER AND USE THEREOF
#95COMPOSITION FOR REPROGRAMMING CELLS INTO PLASMACYTOID DENDRITIC CELLS OR INTERFERON TYPE I-PRODUCING CELLS, METHODS AND USES THEREOF
#96METHODS OF OBTAINING TUMOR-SPECIFIC T CELL RECEPTORS
#97NOVEL METHOD FOR PRODUCING ANTIBODIES
#98DENDRITIC CELL ACTIVATING CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF
#99GENE MODIFIED IPSC DERIVED CELLULAR COMPOSITIONS FOR REGENERATION AND IMMUNE MODULATION
#100METHOD FOR PREPARING DENDRITIC CELL USING PLATELET LYSATE
#101METHOD FOR GENERATING HUMAN DENDRITIC CELLS FOR IMMUNOTHERAPY
#102METHOD FOR PREPARING IMMUNOGENICITY-ENHANCED CD103+ FCGR3+ DENDRITIC CELL BY TREATMENT WITH INTERLEUKIN-33 AND PHARMACEUTICAL COMPOSITION COMPRISING SAME DENDRITIC CELL FOR CANCER IMMUNOTHERAPY
#103TREATMENT OF DISC DEGENERATIVE DISEASE AND STIMULATION OF PROTEOGLYCAN SYNTHESIS BY FIBROBLAST CONDITIONED MEDIA AND FORMULATIONS THEREOF
#104Systems For Producing Cellular Immunotherapeutics And Methods Of Use Thereof
#105GENETICALLY ENGINEERED DENDRITIC CELLS TO ACTIVATE PROTEIN SPECIFIC T CELLS FOR THE TREATMENT OF VIRAL AND OTHER PATHOGENIC INFECTIONS
#106VIRUS SPECIFIC T-CELLS AND METHODS OF TREATING AND PREVENTING VIRAL INFECTIONS
#107CELL THERAPY COMPOSITIONS AND METHODS OF USE THEREOF
#108ENHANCEMENT OF ANTITUMOR EFFECT OF IMMUNE CHECKPOINT INHIBITOR THROUGH ADMINISTRATION OF INTESTINAL RUMINOCOCCACEAE BACTERIUM
#109CHIMERIC ANTIGEN RECEPTOR DENDRITIC CELLS (CAR-DCS) AND METHODS OF MAKING AND USING SAME
#110PHARMACEUTICAL COMPOSITION, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#111ENGINEERED CELLS AND METHODS OF USE
#112Multilamellar RNA Nanoparticles and Methods of Sensitizing Tumors to Treatment with Immune Checkpoint Inhibitors
#113ALDH1 ANTIGEN-PULSED DENDRITIC CELLS
#114IMMUNOTHERAPY
#115METHODS FOR TREATING CANCER AND AUTOIMMUNE AND INFLAMMATORY DISEASES
#116COMPOSITIONS AND METHODS FOR MODULATION OF SIRPALPHA-MEDIATED SIGNALING
#117SARS-COV2-SPECIFIC T CELL COMPOSITIONS AND THEIR USE IN TREATING AND PREVENTING CORONAVIRUS AND OTHER RESPIRATORY VIRUS INFECTIONS
#118T CELL RECEPTOR (TCR) COMPOSITIONS AND METHODS FOR OPTIMIZING ANTIGEN REACTIVE T-CELLS
#119LIPIDS AS SYNTHETIC VECTORS TO ENHANCE ANTIGEN PROCESSING AND PRESENTATION EX-VIVO IN DENDRITIC CELL THERAPY
#120ARTIFICIAL ANTIGEN PRESENTING CELL SYSTEM AND USES THEREOF
#121Methods, kits, and compositions for enhancing cellular therapy
#122SYSTEMS AND METHODS TO MODEL ADAPTIVE IMMUNE RESPONSES
#123METHOD FOR PROVIDING INFORMATION FOR DIAGNOSING OR PREDICTING PROGNOSIS OF CANCER BY MEASURING EXPRESSION LEVEL OF TIM-3 IN CD11B+ CELLS
#124MONOCYTE PURIFICATION METHOD IN PERIPHERAL BLOOD RAW MATERIAL COLLECTION/ FREEZING-THAWING STEP
#125METHODS OF OBTAINING TUMOR-SPECIFIC T CELL RECEPTORS
#126AUTOLOGOUS DENDRITIC CELL VACCINE KIT AND USES
#127A UNIVERSAL ADOPTIVE IMMUNOTHERAPY APPROACH TO TREAT COVID-19 AND FUTURE EMERGING INFECTIOUS DISEASES
#128METHOD FOR T CELL ACTIVATION FOR CANCER TREATMENT
#129Peptide-HLA complexes and methods of producing same
#130METHOD FOR THE PRODUCTION OF MATURE DENDRITIC CELLS IN VITRO USING A BACTERIAL LYSATE
#131CDCA1-derived peptide and vaccine containing same
#132FIBROBLAST-BASED IMMUNOTHERAPY OF GRAVES DISEASE
#133TREATMENT OF AUTOIMMUNITY AND TRANSPLANT REJECTION THROUGH ESTABLISHMENT AND/OR PROMOTION OF TOLEROGENIC PROCESSES BY FIBROBLAST-MEDIATED REPROGRAMMING OF ANTIGEN PRESENTING CELLS
#134Dendritic cell generator
#135A MIXTURE OF MRNA TO ENHANCE THE POTENCY OF DENDRITIC CELLS
#136DAP12 constructs and their use to enhance DC vaccines and immunotherapies
#137COMBINATION IMMUNOTHERAPIES FOR TREATMENT OF CANCER
#138SYSTEMS AND METHODS FOR CELL CULTURING
#139TEIPP PEPTIDE VARIANT AND USES THEREOF
#140Systems and methods for cell culturing
#141COMPOSITIONS AND USES THEREOF
#142METHODS OF OBTAINING TUMOR-SPECIFIC T CELL RECEPTORS
#143MODULATION OF STIMULATORY AND NON-STIMULATORY MYELOID CELLS
#144METHODS OF OBTAINING TUMOR-SPECIFIC T CELL RECEPTORS
#145METHODS OF OBTAINING TUMOR-SPECIFIC T CELL RECEPTORS
#146Detection of a defect on HLA-E restricted CD8+ T regulatory cells
#147Method for treating type I diabetes with peptide-loaded dendritic cells
#148Method for treating multiple sclerosis with peptide-loaded dendritic cells
#149IMMUNOTHERAPIES FOR TARGETING OF TUMOR VASCULATURE
#150Methods to Enhance Tumor Immunogenicity and Compositions for Autologous Cancer Immunotherapeutic Products Using Modified Tumor Cells and Modified Dendritic Cells
#151Dendritic cell generating apparatus and method
#152COMPOSITIONS FOR REPROGRAMMING CELLS INTO DENDRITIC CELLS OR ANTIGEN PRESENTING CELLS, METHODS AND USES THEREOF
#153EX VIVO ANTIGEN-PRESENTING CELLS OR ACTIVATED CD-POSITIVE T CELLS FOR TREATMENT OF CANCER
#154Engineered Artificial Antigen Presenting Cells for Tumor Infiltrating Lymphocyte Expansion
#155Engineered Artificial Antigen Presenting Cells for Tumor Infiltrating Lymphocyte Expansion
#156Systems and methods for cell culturing
#157Systems for producing cellular immunotherapeutics and methods of use thereof
#158METHOD FOR OBTAINING GLOBALLY ACTIVATED MONOCYTES
#159EX VIVO GENERATION OF IMMUNOCYTES RECOGNIZING BROTHER OF THE REGULATOR OF IMPRINTED SITES (BORIS) EXPRESSING CANCER STEM CELLS
#160COMPOSITIONS AND METHODS FOR DETECTING HIV LATENCY, TREATING HIV INFECTION, AND REVERSING HIV LATENCY
#161STIMULATION OF DENDRITIC CELL ACTIVITY BY HOMOTAURINE AND ANALOGUES THEREOF
#162Systems and methods for cell culturing
#163DENDRITIC CELL IMMUNOTHERAPY
#164Methods of cancer treatment using activated t cells
#165VIRUS SPECIFIC T-CELLS AND METHODS OF TREATING AND PREVENTING VIRAL INFECTIONS
#166INDUCTION OF INFECTIOUS TOLERANCE BY EX VIVO REPROGRAMMED IMMUNE CELLS
#167METHOD FOR T CELL ACTIVATION FOR CANCER TREATMENT
#168Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR)
#169Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
#170Recombinant adeno-associated virus vectors with CD14 promoter and use thereof
#171METHOD FOR OBTAINING IMMUNO-STIMULATORY DENDRITIC CELLS
#172Antigen-Presenting Neutrophil-Derived Dendritic Cells and Methods of Use Thereof
#173METHOD FOR DETECTING CELLS
#174BACTERIA-DERIVED VESICLES AND USES THEREOF
#175DELIVERY OF BIOMOLECULES TO IMMUNE CELLS
#176ANTIGEN-SPECIFIC T LYMPHOCYTES AND METHODS OF MAKING AND USING THE SAME
#177DENDRITIC HUMAN UNIVERSAL NON-ANTIGEN EDUCAP VACCINE
#178COMPOSITION FOR PREVENTING OR TREATING BENIGN TUMOR
#179NOVEL C-MET AND TMX2 ANTIBODIES
#180ENHANCED DENDRITIC CELL IMMUNE ACTIVATION BY COMBINED INHIBITION OF NR2F6 WITH CANNIBIDIOL
#181MODIFIED PDC LINE FOR SECRETING A CYTOKINE
#182Treatment of SARS-CoV-2 with Dendritic Cells for Innate and/or Adaptive Immunity
#183INTRACELLULAR DELIVERY OF BIOMOLECULES TO ENHANCE ANTIGEN PRESENTING CELL FUNCTION
#184NOVEL METHOD FOR PRODUCING ANTIBODIES
#185METHOD FOR EXPANDING HUMAN DC CELL AND HUMAN DC CELL RESOURCE LIBRARY
#186Cancer antigens and methods
#187THERAPEUTIC CANCER VACCINES DERIVED FROM A NOVEL DENDRITIC CELL LINE
#188TREATMENT METHODS
#189Ex vivo use of modified cells of leukemic origin for enhancing the efficacy of adoptive cell therapy
#190METHODS, KITS, AND COMPOSITIONS FOR ENHANCING CELLULAR THERAPY
#191METHODS OF OBTAINING A MIXED POPULATION OF HUMAN XCR1+ AND PLASMACYTOID DENDRITIC CELLS FROM HEMATOPOIETIC STEM CELLS
#192BETA-GLUCAN METHODS AND COMPOSITIONS THAT AFFECT THE TUMOR MICROENVIRONMENT
#193Oncolytic virus or antigen presenting cell mediated cancer therapy using type I interferon and CD40-ligand
#194Methods of cancer treatment using activated T cells
#195Immunotherapy against several tumors including neuronal and brain tumors
#196TUMOR LYSATE LOADED PARTICLES
#197Immunotherapy against several tumors including neuronal and brain tumors
#198Development of dual whole cell-based vaccine against pancreatic cancer
#199Methods of obtaining tumor-specific T cell receptors
#200COMPOSITIONS AND METHODS FOR COMBINATION THERAPY WITH DENGUE VIRUS AND DENDRITIC CELLS
#201METHODS OF SENSITIZING TUMORS TO TREATMENT WITH IMMUNE CHECKPOINT INHIBITORS
#202Methods and compositions for T cell activation
#203SECURE ACCESS WITH DENDRITIC IDENTIFIERS
#204METHOD FOR PRODUCING T CELLS MODIFIED BY CHIMERIC ANTIGEN RECEPTOR
#205Aptamers for targeted activation of T cell-mediated immunity
#206Immunomodulatory peptides and methods for modulating the immune system in a subject
#207METHOD FOR THE IN VITRO DIFFERENTIATION AND MATURATION OF DENDRITIC CELLS FOR THERAPEUTIC USE
#208METHODS AND COMPOSITION FOR MODULATING IMMUNE RESPONSE AND IMMUNE HOMEOSTASIS
#209Systems and methods for cell culturing
#210Systems and methods for cell culturing
#211SYSTEMS AND METHODS FOR CELL CULTURING
#212Systems and methods for cell culturing
#213Systems and methods for cell culturing
#214Systems and methods for cell culturing
#215Methods of cancer treatment using activated T cells
#216SOMATIC STEM CELLS
#217Generation of dendritic cells from monocytic dendritic precursor cells with GM-CSF in the absence of additional cytokines
#218METHODS FOR THE STIMULATION OF DENDRITIC CELL (DC) PRECURSOR POPULATION "PRE-DC" AND THEIR USES THEREOF
#219Treatment of disc degenerative disease and stimulation of proteoglycan synthesis by fibroblast conditioned media and formulations thereof
#220GENERATION OF HPV-SPECIFIC T-CELLS
#221Method of producing immunotherapy vaccine
#222DENDRITIC CELL POTENCY ASSAY
#223METHOD FOR INCREASING DENDRITIC CELL MIGRATION ABILITY, AND USE THEREOF
#224PEPTIDE EXCHANGE PROTEIN
#225Methods of enriching cell populations for cancer-specific T cells using in vitro stimulation of memory T cells
#226Langerin+ cell targeting
#227Cell population for use in treating cancer
#228Methods for directed differentiation of pluripotent stem cells to immune cells
#229METHODS AND COMPOSITIONS FOR GENERATING AN IMMUNE RESPONSE BY INDUCING CD40 AND PATTERN RECOGNITION RECEPTOR ADAPTERS
#230Dendritic cell generator
#231Composition and method for cultivation, expansion, preservation and/or cell pretreatment
#232METHOD FOR PREPARING PERSONALIZED CANCER VACCINE
#233COMPOSITIONS AND METHODS FOR PRODUCING DENDRITIC CELLS
#234METHOD FOR ACTIVATING HELPER T CELL
#235DELIVERY OF ONCOLYTIC VIRUSES USING DENDRITIC CELLS
#236Methods, kits, and compositions for enhancing cellular therapy
#237ALDH1 ANTIGEN-PULSED DENDRITIC CELLS
#238Bioengineered in vitro 3D model of human atherosclerotic plaque
#239Combination immunotherapies for treatment of cancer
#240METHODS FOR DIRECTED DIFFERENTIATION OF PLURIPOTENT STEM CELLS TO HLA HOMOZYGOUS IMMUNE CELLS
#241Pharmaceutical Composition for Preventing or Treating Autoimmune Disease, and Method for Producing Same
#242VECTORS CONDITIONALLY EXPRESSING THERAPEUTIC PROTEINS, HOST CELLS COMPRISING THE VECTORS, AND USES THEREOF
#243Dendritic cell generating apparatus and method
#244Methods to Enhance Tumor Immunogenicity and Compositions for Autologous Cancer Immunotherapeutic Products Using Modified Tumor Cells and Modified Dendritic Cells
#245HOMEOBOX TRANSCRIPTION FACTOR VENTX REGULATES DIFFERENTIATION AND MATURATION OF HUMAN DENDRITIC CELLS
#246Allogeneic Dendritic Cells For Use In Cancer Treatment
#247INTERFERON PRIMED PLASMACYTOID DENDRITIC CELLS
#248Plasmacytoid Dendritic Cells Having Immune Tolerance, and Method for Producing Same
#249Dendritic cell generating apparatus and method
#250Combination Therapy of Acellular Pro-Tolerogenic and Pro-Inflammatory Preparations for Modulating the Immune System
#251Maturation of dendritic cells
#252Cell model for in vitro evaluation of compound-induced skin sensitization and a constructing method therefor
#253MEDIUM SYSTEM AND METHOD FOR EX VIVO EXPANSION OF NK CELLS
#254METHOD OF GENERATING NATURAL KILLER CELLS AND DENDRITIC CELLS FROM HUMAN EMBRYONIC STEM CELL-DERIVED HEMANGIOBLASTS
#255Molecular system for cancer biology
#256COMPOSITIONS AND METHODS FOR CANCER THERAPY WITH DENGUE VIRUS AND DENDRITIC CELLS
#257Methods and compositions for modulating peripheral immune function
#258IL-13 SUPERKINE: IMMUNE CELL TARGETING CONSTRUCTS AND METHODS OF USE THEREOF
#259Dendritic Cells as a Novel Delivery System for Immunotherapy
#260FILTER CONTAINER FOR SEPARATING CELLS AND FILTER DEVICE FOR SEPARATING CELLS
#261Short-term activated DC1s and methods for their production and use
#262THERAPY AND METHODS OF INTRODUCING IMMATURE DENDRITIC CELLS AND/OR CYTOXIC T LYMPHOCYTE AND ANTI PD-1 / PD-L1 ANTIBODY FOR TREATMENT OF TUMORS
#263Compositions for reprogramming cells into dendritic cells or antigen presenting cells, methods and uses thereof
#264Methods of preparing an isolated population of dendritic cells and methods of treating cancer using same
#265Modulation of stimulatory and non-stimulatory myeloid cells
#266Engineered cells and methods of use
#267Cancer vaccine composition
#268Three-dimensional in vitro lung model, process for preparing said model, and its use for determining and /or predicting the sensitizing effects of inhalable products
#269TARGET PEPTIDES FOR CANCER THERAPY AND DIAGNOSTICS
#270Ex vivo antigen-presenting cells or activated CD-positive T cells for treatment of cancer
#271NEW USE
#272Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy
#273Extracellular vesicles and methods and uses thereof
#274DENDRITIC CELL PREPARATIONS, COMPOSITIONS THEREOF AND METHODS OF USING SAME
#275Engineered artificial antigen presenting cells for tumor infiltrating lymphocyte expansion
#276PERSONALIZED VACCINES
#277Pharmaceutical composition for preventing or treating metabolic diseases, comprising bacteroides acidifaciens as active ingredient
#278Humanized mouse model
#279METHOD FOR INDUCING TRANSDIFFERENTIATION OF IMMUNE CELLS BASED ON EXOSOMES
#280Combination immunotherapies for treatment of cancer
#281Cancer vaccines and vaccination methods
#282METHODS AND COMPOSITIONS RELATED TO Th-1 DENDRITIC CELLS
#283Compositions and methods for combination therapy with dengue virus and dendritic cells
#284Induced dendritic cells and uses thereof
#285METHOD FOR MANUFACTURING NATURAL KILLER T (NKT) CELL - STIMULATING DENDRITIC CELL, METHOD FOR MANUFACTURING CELL COMPOSITION CONTAINING THE NKT CELL STIMULATING DENDRITIC CELL AND NKT CELL, AND CELL COMPOSITION CONTAINING THEREOF
#286Agents that engage antigen-presenting cells through dendritic cell asialoglycoprotein receptor (DC-ASGPR)
#287Generation of HPV-specific T-cells
#288Enhancing the T-cell stimulatory capacity of human antigen presenting cells in vitro and in vivo and its use in vaccination
#289Detection of CD5 and methods and compositions for modulating CD5
#290Induced pluripotent stem cells produced from dendritic cells
#291METHOD FOR MEASURING IMMUNOGENICITY OF PROTEIN AGENT
#292In vitro neonatal biomimetic (nMIMIC) model and methods of using same
#293TRANSFECTION OF DENDRITIC CELLS AND METHODS THEREFOR
#294Compositions and methods for activating antigen presenting cells with chimeric poliovirus
#295Composition for promoting maturation of dendritic cell containing fusion protein of Rv2299c and ESAT-6
#296Cell therapy compositions and methods of use thereof
#297SOMATIC STEM CELLS
#298Development of dual whole cell-based vaccine against pancreatic cancer
#299METHOD OF TREATING DISEASES USING KINASE MODULATORS
#300Tumor-associated dendritic cell preparations and uses thereof